You are here

Home » Safety First: The Importance of Interpreters & Translated Documents in Preventing Patient Harm

Safety First: The Importance of Interpreters & Translated Documents in Preventing Patient Harm

This webinar occurred on October 7, 2020, and expires on October 8, 2021

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Utilize interpreters and translated documents to promote quality care and safety among limited English proficiency (LEP) and non-English proficiency (NEP) patients.
  • Recognize and assess patient needs for an interpreter.
  • Determine the best method of providing language services for various clinical encounters.
  • Discuss overall best practices for using an interpreter.

Speaker Biographies

Deborah Rader

Deborah Rader serves as the Interpreter Services Program Manager in the Center for Health Equity & Wellness at MultiCare Health System.  In this position, she provides oversight of language and translation services for patients and staff in hospitals and clinics throughout the service area.  Deborah is a member of S.A.I.L., a Northwest alliance of local healthcare systems, working to make interpretation a better experience for the patient and provider, as well as finding new ways to provide these needed services to the community.  She has been in this role with MultiCare for seven years and is committed to promoting access to language services for patients and their family members who need them.

 

 

 

 

Jamilia Sherls-Jones, DNP, MPH, RN, CDP, CPN

Dr. Jamilia Sherls-Jones is the Director of Health Equity in the Center for Health Equity & Wellness at MultiCare Health System. She oversees cultural diversity education, health equity initiatives, community health needs assessments, and interpreter services for the system.

Dr. Sherls-Jones has over ten years of experience in chronic disease prevention & management, community partnership development, pediatric and school nursing, cultural competency, health equity and addressing health disparities. In the past, she has presented on health equity and community benefit at state and national conferences, on webinars, and on podcasts. Dr. Sherls-Jones has received numerous awards for her work, including “40 Under 40” recognition for professional achievement and community involvement in the Puget Sound region. Under her leadership, MultiCare was recognized by the American Hospital Association (AHA) for having a strong track record of addressing health equity in Washington and was selected as one of ten health systems in the nation to participate in the first AHA Hospital Community Cooperative (HCC) Program.

Dr. Sherls-Jones earned her BS in Biology from the University of Puget Sound, her MPH in Community Health and Prevention from Drexel University, and her BSN, MSN and DNP from Thomas Jefferson University. She is also a certified diversity professional and a certified pediatric nurse. Dr. Sherls-Jones is a member of many local and national boards and organizations related to health care and academia.


Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Federation of State Medical Boards designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Alden Roberts, MD
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.
However, the Washington Medical Commission gratefully acknowledges the unrestricted educational grant from the FSMB Foundation in the amount of  $10,000 to support this activity.

Federation of State Medical Boards Logo

 

 

 

Disclosure of Commercial Interest

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity and promote improvements or quality in healthcare. All persons in the position to control the content of an education activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. 

The speakers, course director and planners at the Federation of State Medical Boards and the Washington Medical Commission have no relevant financial interests to disclose.

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

No speakers or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.